| Literature DB >> 20551139 |
Fengbiao Zhou1, Chunhong Cui, Yuqing Ge, Hong Chen, Qiuping Li, Zhiyuan Yang, Guoqiang Wu, Shuhui Sun, Kangli Chen, Jianxin Gu, Jianhai Jiang, Yuanyan Wei.
Abstract
CD133 is widely used as a marker for the isolation and characterization of normal and cancer stem cells. The dynamic alternation of CD133 glycosylation contributes to the isolation of normal and cancer stem cells, and is supposed to be associated with cell differentiation. Although CD133 has been identified as a N-glycosylated protein, the specific glycosylation status of CD133 remain unclear. Here, we found that CD133 could be sialylated in neural stem cells and glioma-initiating cells, and the sialyl residues attach to CD133 N-glycan terminal via alpha2,3-linkage. Furthermore, desialylation of CD133 by neuraminidase specifically accelerates its degradation in lysosomes-dependent pathway. Taken together, our results characterized CD133 as an alpha2,3-sialylated glycoprotein and revealed that the sialylation modification contributes to the stability of CD133 protein, providing clues to understanding the function of CD133 molecular and to understanding the utility of glycosylated CD133 epitopes in defining neural stem cells and tumour-initiating cells.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20551139 DOI： 10.1093/jb/mvq062
Source DB: PubMed Journal: J Biochem ISSN： 0021-924X Impact factor: 3.387